Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index.
Takamasa OhkiMayuko KondoYuki KarasawaSatoshi KawamuraShuuya MaeshimaKentaro KojimaMichiharu SekiNobuo TodaYoshinobu ShiodaKazumi TagawaPublished in: Advances in therapy (2017)
Bayer Yakuhin, Ltd.
Keyphrases